Elevate Campuses Limited Schedules November 12 Results Review
Key highlights
- Elevate Campuses Limited will consider September 30, 2026 quarter and half-year results on November 12, 2026.
- The company reported June-quarter revenue of ₹228.06 crore and profit of ₹34.06 crore in the supplied results information.
- June 2026 standalone net sales were ₹30.80 crore and standalone net profit was ₹3.34 crore.
- The trading window is closed from October 1, 2026 through November 14, 2026.
powered by IRIS

Elevate Campuses Limited is scheduled to consider unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026, at its November 12, 2026 board meeting. The filing follows the company’s reported June-quarter revenue of ₹228.06 crore and profit of ₹34.06 crore, while standalone data showed materially smaller operations.
Know Elevate Campuses inside out
Results, valuation, peers and who's buying, in one view.
What will Elevate Campuses Limited consider on November 12?
Elevate Campuses Limited has informed BSE that its board will meet on November 12, 2026, to consider and approve unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2026. The results will be subject to limited review, according to the board-meeting intimation dated November 5.
The disclosure identifies a financial-results agenda and does not announce a dividend, bonus issue, share split, acquisition, or other corporate action. Any such action, if approved separately, would require its own disclosure and the relevant record-date process.
The September-quarter announcement is significant because it will provide the next set of reported financial data following the June-quarter results. Investors will be able to compare the standalone and consolidated statements, which represent different reporting scopes and should not be treated as directly interchangeable figures.
How did the results announcement unfold?
Elevate Campuses issued the board-meeting intimation on November 5, 2026, confirming the November 12 meeting. The company had previously disclosed that the trading window for its securities would remain closed from October 1, 2026, through November 14, 2026.
The trading-window closure was linked to the upcoming September-quarter and half-year financial results. The company’s earlier September 30 communication had said the window would remain shut until 48 hours after declaration of the unaudited standalone and consolidated results. The November 14 date is consistent with that stated restriction around the results process.
The company had also scheduled a Q2 and H1 FY27 earnings conference call for November 16, 2026. The supplied disclosures do not provide the timing of the call, its participants, or any earnings guidance. They establish only that results review and investor communication are planned in sequence.
What do Elevate Campuses’ latest reported figures show?
Elevate Campuses’ reported figures for the quarter ended June 2026 included revenue of ₹228.06 crore and profit of ₹34.06 crore. Another results summary in the supplied information described sales of ₹219 crore and net profit of ₹34 crore for the same quarter, indicating that figures may have been presented using a different reporting basis or rounding convention.
The standalone quarterly snapshot for June 2026 showed net sales of ₹30.80 crore, operating profit before depreciation, interest and tax excluding other income of ₹7.99 crore, and standalone net profit of ₹3.34 crore. The snapshot compared these with March 2026 net sales of ₹30.52 crore and standalone net profit of ₹4.80 crore.
On that standalone comparison, net sales increased 0.92% quarter on quarter, while operating profit declined 6.44% and standalone net profit fell 30.42%. Interest expense rose 16.97% to ₹19.02 crore. The operating profit margin excluding other income was 25.94%, compared with 27.98% in the March quarter.
Got a follow-up? Ask IRIS
Why does the September-quarter filing matter to investors?
The September-quarter filing will give investors the first official update on Elevate Campuses’ performance after the June-quarter numbers cited in the available disclosures. The results should clarify the company’s revenue, profitability, interest cost and margins for both the three-month period and the first half of the financial year.
The standalone June data made interest expense a relevant line item to monitor, as it increased to ₹19.02 crore from ₹16.26 crore in the preceding quarter. The September results will show whether that movement continued, moderated, or changed, but the current filing makes no statement about expected financial performance.
The distinction between consolidated and standalone reporting also matters. Consolidated results include the financial performance of entities covered under consolidation, while standalone results relate to the parent company’s individual accounts. The disclosed June revenue and profit figures are much higher than the standalone snapshot, so investors should identify the accounting basis before making comparisons.
The company was admitted to dealings on the exchange effective September 30, 2026, according to the supplied exchange information. As a listed company, its board-meeting notice, trading-window process and subsequent result disclosures form part of the information available to public-market participants.
What should investors watch after the board meeting?
Investors should watch for the approved September-quarter and half-year financial statements after the November 12 board meeting. Key reported measures will include revenue, net profit, operating profit, margins, interest expense and any differences between the standalone and consolidated performance.
The November 16 earnings conference call is the next disclosed event after the board meeting. The company has not provided forecasts, targets, dividend proposals or other operational updates in the filing, so any assessment of future performance should remain based on the actual results and subsequent official disclosures.
Conclusion
Elevate Campuses has scheduled a November 12 board meeting to approve unaudited results for the quarter and half-year ended September 30, 2026. Its last available figures show a June-quarter revenue figure of ₹228.06 crore and profit of ₹34.06 crore in one reported summary, alongside standalone net sales of ₹30.80 crore and net profit of ₹3.34 crore.
The next confirmed milestones are the results approval process on November 12 and the planned Q2 and H1 FY27 earnings conference call on November 16. Investors will need the released standalone and consolidated statements to assess the company’s September-quarter performance, including movements in margins and interest costs.


